Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-03-25

Clinical Trial Update: The Development of New Functions of Esculin and Digitalis Glycosides Eye Drops: A Study on the Treatment of Presbyopia [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating Esculin eye drops and Digitalis glycosides eye drops for presbyopia has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Digitalis glycosides eye drops
  • Esculin eye drops

Snippet

Sponsor: Shanxi Eye Hospital | Conditions: Presbyopia | Phase 4 | Status: COMPLETED | Results posted: 2026-03-25